Security key
61225M102
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)
CUSIP: 61225M102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 84,039,109
- Total 13F shares
- 62,196,889
- Share change
- +2,670,938
- Total reported value
- $280,514,086
- Put/Call ratio
- 0%
- Price per share
- $4.51
- Number of holders
- 115
- Value change
- +$11,963,150
- Number of buys
- 76
- Number of sells
- 34
Report period
Q2 2025
Institutions
115
Top holders
10
GLUE full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Monte Rosa Therapeutics, Inc. SEC filings
Monte Rosa Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61225M102
Recent filing periods:
Top shareholders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
6.3%
|
3,840,165
|
$20,045,661 | $0 | 31 Dec 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
5.5%
|
3,360,000
|
$17,539,200 | $0 | 09 Apr 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
2.8%
from 13D/G
|
4,674,108
|
$21,687,861 | — | 31 Mar 2025 | |
| NEA Management Company, LLC |
13F
|
Company |
9.2%
|
7,692,298
|
$35,692,263 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7.9%
|
6,644,136
|
$30,830,000 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
6.7%
|
5,660,132
|
$26,263,012 | — | 31 Mar 2025 | |
| Versant Venture Management, LLC |
13F
|
Company |
6.7%
|
5,652,922
|
$26,229,558 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.8%
|
4,916,095
|
$22,810,681 | — | 31 Mar 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.5%
|
4,645,548
|
$21,555,343 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
3,100,036
|
$14,384,167 | — | 31 Mar 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
1.8%
|
1,472,331
|
$6,831,616 | — | 31 Mar 2025 | |
| Alphabet Inc. |
13F
|
Company |
1.7%
|
1,464,015
|
$6,793,030 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,004,062
|
$4,659,751 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.95%
|
801,257
|
$3,717,832 | — | 31 Mar 2025 | |
| Parkwood LLC |
13F
|
Company |
0.84%
|
708,000
|
$3,285,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
422,090
|
$1,958,499 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
373,207
|
$1,731,681 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.44%
|
371,738
|
$1,724,864 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
361,535
|
$1,677,522 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
356,112
|
$1,652,359 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.39%
|
330,467
|
$1,533,367 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.34%
|
287,000
|
$1,331,680 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.31%
|
262,990
|
$1,220,273 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
229,536
|
$1,065,046 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.27%
|
223,130
|
$1,035,323 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.22%
|
187,731
|
$871,072 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.2%
|
172,078
|
$798,442 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
164,145
|
$761,634 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
164,100
|
$761,424 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.16%
|
136,575
|
$633,709 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.14%
|
117,672
|
$545,998 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.14%
|
117,307
|
$544,304 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.12%
|
100,406
|
$465,884 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.11%
|
96,345
|
$447,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
91,514
|
$424,625 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.1%
|
86,014
|
$399,105 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
62,239
|
$288,780 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
53,338
|
$247,488 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
51,725
|
$240,004 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
48,698
|
$225,959 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
46,210
|
$214,414 | — | 31 Mar 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
37,635
|
$174,626 | — | 31 Mar 2025 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.04%
|
37,574
|
$174,343 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
35,346
|
$164,006 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
35,152
|
$163,105 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
35,140
|
$163,050 | — | 31 Mar 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.04%
|
32,586
|
$151,199 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
31,114
|
$144,369 | — | 31 Mar 2025 | |
| Corton Capital Inc. |
13F
|
Company |
0.03%
|
29,348
|
$136,175 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
28,555
|
$132,495 | — | 31 Mar 2025 |
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q2 2025
As of 30 Jun 2025,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,196,889 shares.
The largest 10 holders included
NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, Versant Venture Management, LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc., Avoro Capital Advisors LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and FMR LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
105
Q2 2025 holders
115
Holder diff
10
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.